Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M
Department of Surgery, National Cancer Institute of Milan, Italy.
Ann Surg Oncol. 2003 Apr;10(3):291-6. doi: 10.1245/aso.2003.06.002.
The natural history of chordoma is characterized by a high failure rate and a poor functional outcome. The purpose of this study was to review the long-term outcome of our institutional experience.
The clinical features, type of treatment, pathologic assessment, and follow-up of 56 consecutive patients with chordoma were reviewed.
Fifty sacral and six mobile spine chordomas (median size, 13 cm; range, 2-30 cm) were treated at our center between January 1933 and December 2000. Twenty-eight patients affected by sacrococcygeal chordoma and operated on after 1977 form the basis of our study. Surgical margins were rated as wide in 11 cases, marginal in 13 cases, and intralesional in 4 cases. The median follow-up was 71 months (range, 15-200 months). Seventeen patients' disease recurred. Ten patients died as a result of disease. Nine patients remained continuously free of disease. The estimated 5- and 10-year overall survival was, respectively, 87.8% and 48.9%; disease-free survival was 60.6% and 24.2%. Radiotherapy was considered for marginal and intralesional resections.
High sacral amputation can achieve a good rate of wide-margin resections for sacrococcygeal chordomas. Adjuvant radiotherapy may offset the negative effect in the prognosis of marginal resections.
脊索瘤的自然病程特点是高失败率和不良功能预后。本研究的目的是回顾我们机构的长期治疗结果。
回顾了56例连续的脊索瘤患者的临床特征、治疗类型、病理评估和随访情况。
1933年1月至2000年12月期间,我们中心共治疗了50例骶骨脊索瘤和6例活动脊柱脊索瘤(中位大小为13 cm;范围为2 - 30 cm)。本研究以1977年后接受手术的28例受骶尾脊索瘤影响的患者为基础。手术切缘在11例中被评为广泛,13例为边缘性,4例为瘤内。中位随访时间为71个月(范围为15 - 200个月)。17例患者疾病复发。10例患者因疾病死亡。9例患者持续无病生存。估计5年和10年总生存率分别为87.8%和48.9%;无病生存率分别为60.6%和24.2%。对于边缘性和瘤内切除考虑进行放疗。
高位骶骨截肢术可实现骶尾脊索瘤的高广泛切缘切除率。辅助放疗可能抵消边缘性切除对预后的负面影响。